Advanced search
Publication Cover
Clinical and Experimental Gastroenterology Volume 15, 2022 - Issue
Submit an article Journal homepage
132
Views
1
CrossRef citations to date
0
Altmetric
Research Letter

Non-Invasive Risk Stratification in NAFLD/NASH Patients for Screening EGD

John Romano1 Division of Gastroenterology and Hepatology, Medical University of South Carolina, Charleston, SC, USACorrespondence[email protected]
,
Thaer Abdelfattah2 Division of Gastroenterology and Hepatology, Central Virginia VA Health Care System, Richmond, VA, USA
,
Paul P Manka3 Department of Internal Medicine, University Hospital, Knappschaftskrankenhaus, Ruhr-University Bochum, Bochum, Germany
,
Michael Fuchs2 Division of Gastroenterology and Hepatology, Central Virginia VA Health Care System, Richmond, VA, USA;4 Division of Gastroenterology and Hepatology, Virginia Commonwealth University, Richmond, VA, USA
&
Wing-Kin Syn1 Division of Gastroenterology and Hepatology, Medical University of South Carolina, Charleston, SC, USA;5 Section of Gastroenterology, Ralph H Johnson VAMC, Charleston, SC, USA;6 Department of Physiology, Faculty of Medicine and Nursing, University of the Basque Country, Universidad del Pa S Vasco/Euskal Herriko Univertsitatea (UPV/EHU), Leioa, Spain
Pages 1-3 | Published online: 10 Jan 2022

References

  • de Franchis R Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol. 2010;53:762–768
  • Augustin S, Altamirano J, González A, et al. Effectiveness of combined pharmacologic and ligation therapy in high risk patients with acute esophageal variceal bleeding. Am J Gastroenterol. 2011;106:1787–1795. doi:10.1038/ajg.2011.173
  • Garcia-Tsao G, Abraldes JG, Berzigotti A, et al. Portal hypertensive bleeding in cirrhosis: risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases. Hepatology. 2017;65:310. doi:10.1002/hep.28906
  • de Franchis R Expanding consensus in portal hypertension: report of the Baveno VI Consensus Workshop: stratifying risk and individualizing care for portal hypertension. J Hepatol. 2015;63:743–752
  • Karagiannakis DS, Voulgaris T, Koureta E, et al. Role of Spleen Stiffness Measurement by 2D-Shear Wave Elastography in Ruling Out the Presence of High-Risk Varices in Cirrhotic Patients. Digestive Dis Sci. 2019;64:2653–2660. doi:10.1007/s10620-019-05616-4
  • D’Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol. 2006;44:217–231. doi:10.1016/j.jhep.2005.10.013
  • Augustin S, Pons M, Maurice JB, et al. Expanding the Baveno VI criteria for the screening of varices in patients with compensated advanced chronic liver disease. Hepatology. 2017;66(6):1980–1988. doi:10.1002/hep.29363
  • Petta S, Sebastiani G, Bugianesi E, et al. Non-invasive prediction of esophageal varices by stiffness and platelet in non-alcoholic fatty liver disease cirrhosis. J Hepatol. 2018;69(4):878–885. doi:10.1016/j.jhep.2018.05.019
  • Tarantion G, Citro V, Balsano C. Liver-spleen axis in nonalcoholic fatty liver disease. Exp Rev Gastroenterol Hepatol. 2021;7:759–769. doi:10.1080/17474124.2021.1914587

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.